Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Vanitha Venkatasubramaniam

Pharma Talks: AI in Pharma Communication – Breaking the Myths, Navigating Asia l Part 1

Watch the second part of the conversation: https://youtu.be/9wQPF4W6qNQ [https://youtu.be/9wQPF4W6qNQ] This episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation. 👥 Guests in this episode: Bruno Senouci - co-CEO at DRCOM Gwenael Meneux - co-CEO at DRCOM Key Topics: AI impact on pharma communication Regional differences in Asia healthcare markets Global to local content adaptation strategies Follow Viseven and Nataliya, Bruno and Gwenael in social media: https://www.linkedin.com/in/andreychuk/ [https://www.linkedin.com/in/andreychuk/] https://www.linkedin.com/in/bsenouci/ [https://www.linkedin.com/in/bsenouci/] https://www.linkedin.com/in/gwenael-meneux/?locale=fr [https://www.linkedin.com/in/gwenael-meneux/?locale=fr]

Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Vanitha Venkatasubramaniam

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Vanitha Venkatasubramaniam, Associate Director at Novo Nordisk, for an honest conversation about where pharma stands today with AI — and where the real opportunity lies ahead. Vanitha brings a refreshingly balanced view: the skills aren't fully there yet, but the intention from leadership is. And the most exciting work? Using AI to genuinely improve the experience for HCPs and patients. Key takeaways: AI adoption in pharma is accelerating faster than most teams are ready for Leadership intent is strong — but building the right skills across teams remains the gap Generative AI is already embedded in day-to-day workflows — Copilot, emails, meetings The biggest opportunity is using AI to enhance experiences for HCPs and patients, not just internal efficiency Think beyond existing marketing models — combine them with technology to create innovative go-to-market approaches 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)

Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Maryna Alexeychuk

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Maryna Alexeychuk, Head of Strategic Accounts at Viseven, for a grounded take on what AI in pharma marketing should actually look like in practice. Her message is clear: AI shouldn't be a separate initiative — it should live inside the tools and processes marketers already use every day. Key takeaways: * AI should be embedded where marketers already work — content, campaigns, reporting * Contextual, always-on AI beats standalone tools nobody opens twice * AI won't replace pharma marketers — human context in engagement is irreplaceable * Before choosing a technology, map your end-to-end processes and define your goal first 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)

Pharma Talks Live from Reuters Pharma Barcelona with Marc Koolen

In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond. 👥 Guest in this episode: Marc Koolen - Omnichannel Head GSK Follow Viseven and Nataliya and Marck in social media: https://www.linkedin.com/in/andreychuk/ [https://www.linkedin.com/in/andreychuk/] https://www.linkedin.com/in/marc-koolen/ [https://www.linkedin.com/in/marc-koolen/]

Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Haider Alleg

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Haider Alleg, pharma strategist turned venture capitalist at Allegory Capital, to explore why AI in pharma commercial operations is still mostly noise — and what it will actually take to change that. With 20 years in pharma and a fresh perspective from the VC world, Haider cuts through the hype and makes a bold claim: this isn't a technology shift. It's a culture shift. Key takeaways: AI in R&D and manufacturing is already mature — commercial operations are just catching up Dark factories and agentic systems show what full automation can look like The biggest opportunity isn't automating tasks — it's re-internalizing operational work with AI Medical and scientific affairs are best positioned to lead the way right now The advice that matters most: get your hands dirty and stay curious 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik) 🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ [https://www.linkedin.com/in/andreychuk/] 🎙️ Haider Alleg → https://www.linkedin.com/in/haideralleg/ [https://www.linkedin.com/in/haideralleg/]